Inclusion Criteria:  Persons with a diagnosis of mild cognitive impairment (MCI) or dementia of any aetiology based on a previous diagnosis by a clinician or scoring above threshold (≤32; MCI ≤32 and dementia ≤27) for cognitive impairment in the Modified Telephone Interview for Cognitive Impairment (TICS-M). Persons screening positive for anxiety (scoring ≥9 in the Geriatric Anxiety Inventory, GAI) or reports subjective complaints of anxiety  Exclusion Criteria:  Persons with severe dementia Persons who are unable to communicate or complete questionnaires Persons who are at high risk of suicide as identified by by the University of Queensland Suicidal Risk Assessment administered at the UQ Psychology clinic which has been modified for use by the Dementia and Neuro Mental Health Research Unit Persons who have major depression as the primary complaint without reported symptoms of anxiety. Persons on existing anxiolytics or antidepressants who have not been on a stable dose for at least 12 weeks before starting the trial and are unable to maintain the same dose for the duration of the trial. Changes to medication will be checked at each therapy and assessment session. Persons who are undergoing psychological therapy or will undergo psychological therapy over the trial duration.  Entry into the study:  Study entry will be determined by discussions with the core investigator team consisting of clinicians and experienced researchers.